Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
25%
OVERLAP
BY WEIGHT
31
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
62%
ALSO IN XBI
XBI
136
HOLDINGS
22%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus XBI)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
| EXELIXIS INC | 1.6% | 1.2% | 1.2% | |
| UNITED THERAPEUTICS CORP | 3.2% | 1.1% | 1.1% | |
| PTC THERAPEUTICS INC | 1.3% | 1.1% | 1.1% | |
| INCYTE CORP | 2.3% | 1.1% | 1.1% | |
| NEUROCRINE BIOSCIENCES INC | 1.2% | 1.1% | 1.1% | |
FTXH Overweight Relative to XBI
| BRISTOL-MYERS SQUIBB CO | 7.3% | |
| JOHNSON & JOHNSON | 7.1% | |
| MERCK & CO. INC. | 7.0% | |
| ELI LILLY & CO | 6.5% | |
| ABBVIE INC | 5.7% | |
| VIATRIS, INC. | 3.8% | |
| PFIZER INC | 3.8% | |
| ZOETIS INC | 3.4% | |
| CARDINAL HEALTH INC | 3.4% | |
| BIOGEN IDEC INC | 2.7% |
FTXH Underweight Relative to XBI
| APELLIS PHARMACEUTICALS, INC. | -1.8% | |
| REVOLUTION MEDICINES, INC. | -1.5% | |
| SUMMIT THERAPEUTICS INC | -1.4% | |
| ERASCA, INC. | -1.3% | |
| MADRIGAL PHARMACEUTICALS, INC. | -1.3% | |
| APOGEE THERAPEUTICS, INC. | -1.3% | |
| SCHOLAR ROCK HOLDING CORP. | -1.2% | |
| CELCUITY INC. | -1.2% | |
| NUVALENT, INC. CLASS A | -1.1% | |
| BEAM THERAPEUTICS, INC. | -1.1% |